Crestchem Limited (CRSTCHM.BO)
INR 193.05
(1.98%)
INR 193.05
(1.98%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 50.8 Million INR | 15.33% |
| 2022 | 14.86 Million INR | 35.64% |
| 2021 | 10.95 Million INR | 4.08% |
| 2020 | 10.52 Million INR | 57.34% |
| 2019 | 6.69 Million INR | 254.74% |
| 2018 | 1.88 Million INR | -26.68% |
| 2017 | 2.57 Million INR | 21.36% |
| 2016 | 2.11 Million INR | 18.75% |
| 2015 | 1.78 Million INR | -24.13% |
| 2014 | 2.35 Million INR | -4.06% |
| 2013 | 2.45 Million INR | -23.56% |
| 2012 | 3.2 Million INR | 37.51% |
| 2011 | 2.33 Million INR | 7.8% |
| 2010 | 2.16 Million INR | 5.72% |
| 2009 | 2.04 Million INR | 77.74% |
| 2008 | 1.15 Million INR | -30.02% |
| 2007 | 1.64 Million INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 4.37 Million INR | 3.24% |
| 2023 Q3 | 4.99 Million INR | -26.42% |
| 2023 Q2 | 6.78 Million INR | 73.14% |
| 2023 Q1 | 3.91 Million INR | -29.83% |
| 2023 FY | 17.14 Million INR | 15.33% |
| 2023 Q4 | 4.23 Million INR | -15.17% |
| 2022 Q1 | 2.96 Million INR | -28.07% |
| 2022 FY | 14.86 Million INR | 35.64% |
| 2022 Q3 | 3.58 Million INR | 31.56% |
| 2022 Q4 | 5.58 Million INR | 55.53% |
| 2022 Q2 | 2.72 Million INR | -7.96% |
| 2021 Q1 | 2.18 Million INR | -14.83% |
| 2021 Q3 | 2.5 Million INR | 269.76% |
| 2021 FY | 10.95 Million INR | 4.08% |
| 2021 Q2 | 678 Thousand INR | -68.97% |
| 2021 Q4 | 4.12 Million INR | 64.36% |
| 2020 FY | 10.52 Million INR | 57.34% |
| 2020 Q4 | 2.56 Million INR | -5.01% |
| 2020 Q3 | 2.7 Million INR | 2.93% |
| 2020 Q2 | 2.62 Million INR | -0.57% |
| 2020 Q1 | 2.63 Million INR | 19.24% |
| 2019 Q1 | 894 Thousand INR | 468.18% |
| 2019 Q3 | 2.62 Million INR | 175.29% |
| 2019 Q4 | 2.21 Million INR | -15.82% |
| 2019 Q2 | 955 Thousand INR | 6.82% |
| 2019 FY | 6.69 Million INR | 254.74% |
| 2018 Q3 | 601 Thousand INR | -11.36% |
| 2018 FY | 1.88 Million INR | -26.68% |
| 2018 Q4 | -242.81 Thousand INR | -140.4% |
| 2018 Q2 | 678 Thousand INR | -20.14% |
| 2018 Q1 | 849 Thousand INR | -12.69% |
| 2017 Q3 | 678 Thousand INR | 100.0% |
| 2017 Q4 | 972.39 Thousand INR | 43.42% |
| 2017 FY | 2.57 Million INR | 21.36% |
| 2017 Q1 | 452 Thousand INR | 36.97% |
| 2017 Q2 | 339 Thousand INR | -25.0% |
| 2016 Q4 | 330 Thousand INR | 23.13% |
| 2016 Q3 | 268 Thousand INR | -58.19% |
| 2016 Q2 | 641 Thousand INR | 183.63% |
| 2016 FY | 2.11 Million INR | 18.75% |
| 2016 Q1 | 226 Thousand INR | 36.97% |
| 2015 Q4 | 165 Thousand INR | 32.0% |
| 2015 Q1 | -1.11 Million INR | -112.39% |
| 2015 Q2 | 63 Thousand INR | 105.64% |
| 2015 FY | 1.78 Million INR | -24.13% |
| 2015 Q3 | 125 Thousand INR | 98.41% |
| 2014 Q4 | 9.01 Million INR | 214.66% |
| 2014 Q2 | 393 Thousand INR | -51.3% |
| 2014 Q1 | 807 Thousand INR | -9.85% |
| 2014 FY | 2.35 Million INR | -4.06% |
| 2014 Q3 | -7.86 Million INR | -2100.25% |
| 2013 FY | 2.45 Million INR | -23.56% |
| 2013 Q2 | 590 Thousand INR | -7.23% |
| 2013 Q4 | 895.19 Thousand INR | 170.45% |
| 2013 Q3 | 331 Thousand INR | -43.9% |
| 2013 Q1 | 636 Thousand INR | -3.67% |
| 2012 Q4 | 660.22 Thousand INR | -32.77% |
| 2012 Q1 | 469 Thousand INR | -71.73% |
| 2012 FY | 3.2 Million INR | 37.51% |
| 2012 Q2 | 539 Thousand INR | 14.93% |
| 2012 Q3 | 982 Thousand INR | 82.19% |
| 2011 Q3 | 334 Thousand INR | 0.0% |
| 2011 Q4 | 1.65 Million INR | 396.63% |
| 2011 FY | 2.33 Million INR | 7.8% |
| 2010 FY | 2.16 Million INR | 5.72% |
| 2009 FY | 2.04 Million INR | 77.74% |
| 2008 FY | 1.15 Million INR | -30.02% |
| 2007 FY | 1.64 Million INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| ANG Lifesciences India Limited | 219.92 Million INR | 76.9% |
| Bacil Pharma Limited | 1.87 Million INR | -2610.351% |
| BDH Industries Limited | 57.03 Million INR | 10.923% |
| Beryl Drugs Limited | 93.77 Million INR | 45.823% |
| Cian Healthcare Limited | 59.19 Million INR | 14.183% |
| Chemo Pharma Laboratories Limited | 1.94 Million INR | -2509.273% |
| Deccan Health Care Limited | 36.24 Million INR | -40.176% |
| DECIPHER LABS LIMITED | 277.6 Million INR | 81.699% |
| Add-Shop E-Retail Limited | 146.52 Million INR | 65.329% |
| Concord Drugs Limited | 91.83 Million INR | 44.679% |
| Gujarat Terce Laboratories Limited | 132.41 Million INR | 61.635% |
| Gujarat Themis Biosyn Limited | 156.84 Million INR | 67.61% |
| Hindustan Bio Sciences Limited | 2.6 Million INR | -1847.62% |
| Ishita Drugs and Industries Limited | 16.46 Million INR | -208.511% |
| Jenburkt Pharmaceuticals Limited | 437.2 Million INR | 88.38% |
| KIMIA BIOSCIENCES LIMITED | 149.52 Million INR | 66.023% |
| Kwality Pharmaceuticals Limited | 248.93 Million INR | 79.592% |
| Makers Laboratories Limited | 83.1 Million INR | 38.869% |
| Medi-Caps Limited | 93.11 Million INR | 45.443% |
| MedPlus Health Services Limited | 2.42 Billion INR | 97.904% |
| Panchsheel Organics Limited | 68.15 Million INR | 25.465% |
| Parmax Pharma Limited | 99.31 Million INR | 48.848% |
| Parnax Lab Limited | 80.59 Million INR | 36.963% |
| Patidar Buildcon Limited | 1.81 Million INR | -2705.22% |
| Phaarmasia Limited | 50.52 Million INR | -0.547% |
| PRAVEG LIMITED | 77.18 Million INR | 34.178% |
| Sunil Healthcare Limited | 438.1 Million INR | 88.404% |
| Syschem (India) Limited | 64.13 Million INR | 20.784% |
| Sanjivani Paranteral Limited. | 208.87 Million INR | 75.678% |
| Sastasundar Ventures Limited | 846.78 Million INR | 94.001% |
| SHAMROCK INDUSTRIAL CO.LTD. | 1.52 Million INR | -3233.5% |
| Smruthi Organics Limited | 261.73 Million INR | 80.59% |
| Source Natural Foods and Herbal Supplements Limited | 31.85 Million INR | -59.471% |
| SUDARSHAN PHARMA INDUSTRIES LI | 146.09 Million INR | 65.225% |
| Trident Lifeline Limited | 46.87 Million INR | -8.388% |
| Transchem Limited | 8.47 Million INR | -499.582% |
| Trinity League India Limited | -1.08 Million INR | 4777.95% |
| Tyche Industries Limited | 182.04 Million INR | 72.093% |
| Vikram Thermo (India) Limited | 104.27 Million INR | 51.281% |
| Vista Pharmaceuticals Limited | 20.16 Million INR | -151.922% |
| Vivanza Biosciences Limited | 4.55 Million INR | -1015.314% |
| Zenith Healthcare Limited | 45.97 Million INR | -10.493% |
| Zenlabs Ethica Limited | 57.89 Million INR | 12.251% |
| Mercury Laboratories Limited | 217.24 Million INR | 76.615% |
| SHELTER PHARMA LIMITED | 12.3 Million INR | -313.012% |
| Vasundhara Rasayans Limited | 145.5 Million INR | 65.086% |
| Bharat Immunologicals & Biologicals Corporation Limited | 184.08 Million INR | 72.402% |
| Roopa Industries Limited | 24.63 Million INR | -106.221% |
| PANJON LTD. | 33.77 Million INR | -50.397% |
| Pharmaids Pharmaceuticals Limited | 76.49 Million INR | 33.586% |
| TIAAN CONSUMER LIMITED | 107 Thousand INR | -47379.011% |
| Anuh Pharma Limited | 263.04 Million INR | 80.687% |
| Emmessar Biotech & Nutrition Limited | 4.32 Million INR | -1075.441% |
| Sandu Pharmaceuticals Limited | 212.9 Million INR | 76.138% |
| Fredun Pharmaceuticals Limited | 360.45 Million INR | 85.906% |
| Trimurthi Limited | 4.81 Million INR | -955.966% |
| Shukra Pharmaceuticals Limited | 83.05 Million INR | 38.831% |
| Norris Medicines Limited | 18.2 Million INR | -179.056% |
| Veerhealth Care Limited | 15.38 Million INR | -230.273% |
| Lactose (India) Limited | 111.66 Million INR | 54.503% |
| OXYGENTA PHARMACEUTICAL LIMITE | 23.78 Million INR | -113.636% |
| Ambalal Sarabhai Enterprises Limited | 280.83 Million INR | 81.91% |
| Gennex Laboratories Limited | 130.37 Million INR | 61.034% |
| Denis Chem Lab Limited | 453.36 Million INR | 88.794% |
| Colinz Laboratories Limited | 31.19 Million INR | -62.839% |
| Godavari Drugs Limited | 359.01 Million INR | 85.849% |
| Zenotech Laboratories Limited | 94.82 Million INR | 46.423% |
| Shree Ganesh Remedies Limited | 104.13 Million INR | 51.215% |
| Bharat Parenterals Limited | 255.97 Million INR | 80.154% |
| Coral Laboratories Limited | 189.75 Million INR | 73.228% |
| Evoq Remedies Limited | 4.51 Million INR | -1024.697% |
| Kerala Ayurveda Limited | 399.64 Million INR | 87.288% |
| KOBO BIOTECH LIMITED | 2.48 Million INR | -1948.49% |
| Natural Capsules Limited | 444.7 Million INR | 88.576% |
| Auro Laboratories Limited | 157.37 Million INR | 67.719% |